Brugada syndrome history and symptoms: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Brugada syndrome}} | {{Brugada syndrome}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 18: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Needs content]] |
Revision as of 04:55, 31 August 2012
Brugada syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Brugada syndrome history and symptoms On the Web |
American Roentgen Ray Society Images of Brugada syndrome history and symptoms |
Risk calculators and risk factors for Brugada syndrome history and symptoms |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
History and Symptoms
- Brugada syndrome is diagnosed when a Type 1 ST-segment elevation is observed in more than one right precordial lead (V1-V3), in the presence or absence of sodium channel blocking agent, and in conjunction with one or more of the following:
- Family history of SCD (<45 years old)
- Documented VF
- Polymorphic ventricular tachycardia
- Coved-type ECGs in family members
- Inducibility of VT with programmed electrical stimulation (PES)
- Syncope
- Nocturnal agonal respiration
- Diagnosis is also considered positive when a Type 2 (saddleback pattern) or Type 3 ST-segment elevation is observed in more than one right precordial lead under baseline conditions and can be converted to the diagnostic Type 1 pattern occurs upon exposure to sodium channel blocker.